NKA is highly abundant in the brain and changes in its function and activity have been implicated in neurodegenerative disorders like Alzheimer’s disease (AD) [81], with its expression being decreased both in the brain tissue derived from AD patients and AD mouse models [82,83]. Here, TAC1 is linked to Alzheimer disease.